These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21418440)

  • 21. Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.
    Yoshimura S; Isobe N; Matsushita T; Masaki K; Sato S; Kawano Y; Ochi H; Kira J
    PLoS One; 2014; 9(4):e95367. PubMed ID: 24736746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical usefulness of oligoclonal bands].
    Falip M; Tintoré M; Jardí R; Duran I; Link H; Montalbán X
    Rev Neurol; 2001 Jun 16-30; 32(12):1120-4. PubMed ID: 11562840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DRB1*03:01 haplotypes: differential contribution to multiple sclerosis risk and specific association with the presence of intrathecal IgM bands.
    de la Concha EG; Cavanillas ML; Cénit MC; Urcelay E; Arroyo R; Fernández Ó; Álvarez-Cermeño JC; Leyva L; Villar LM; Núñez C
    PLoS One; 2012; 7(2):e31018. PubMed ID: 22363536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude.
    Lechner-Scott J; Spencer B; de Malmanche T; Attia J; Fitzgerald M; Trojano M; Grand'Maison F; Gomez JA; Izquierdo G; Duquette P; Girard M; Grammond P; Oreja-Guevara C; Hupperts R; Bergamaschi R; Boz C; Giuliani G; van Pesch V; Iuliano G; Fiol M; Cristiano E; Verheul F; Saladino ML; Slee M; Barnett M; Deri N; Flechter S; Vella N; Shaw C; Herbert J; Moore F; Petkovska-Boskova T; Jokubaitis V; Butzkueven H;
    Mult Scler; 2012 Jul; 18(7):974-82. PubMed ID: 22185806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study.
    Banwell B; Bar-Or A; Arnold DL; Sadovnick D; Narayanan S; McGowan M; O'Mahony J; Magalhaes S; Hanwell H; Vieth R; Tellier R; Vincent T; Disanto G; Ebers G; Wambera K; Connolly MB; Yager J; Mah JK; Booth F; Sebire G; Callen D; Meaney B; Dilenge ME; Lortie A; Pohl D; Doja A; Venketaswaran S; Levin S; Macdonald EA; Meek D; Wood E; Lowry N; Buckley D; Yim C; Awuku M; Cooper P; Grand'maison F; Baird JB; Bhan V; Marrie RA
    Lancet Neurol; 2011 May; 10(5):436-45. PubMed ID: 21459044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
    Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
    Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of HLA-A and -DRB1 on age at onset, disease course and severity in Scandinavian multiple sclerosis patients.
    Smestad C; Brynedal B; Jonasdottir G; Lorentzen AR; Masterman T; Akesson E; Spurkland A; Lie BA; Palmgren J; Celius EG; Hillert J; Harbo HF
    Eur J Neurol; 2007 Aug; 14(8):835-40. PubMed ID: 17662002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DQB1*0602 allele shows a strong association with multiple sclerosis in patients in Malaga, Spain.
    Fernández O; Fernández V; Alonso A; Caballero A; Luque G; Bravo M; León A; Mayorga C; Leyva L; de Ramón E
    J Neurol; 2004 Apr; 251(4):440-4. PubMed ID: 15083289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA-DRB1*15:01 and multiple sclerosis: a female association?
    Irizar H; Muñoz-Culla M; Zuriarrain O; Goyenechea E; Castillo-Triviño T; Prada A; Saenz-Cuesta M; De Juan D; Lopez de Munain A; Olascoaga J; Otaegui D
    Mult Scler; 2012 May; 18(5):569-77. PubMed ID: 22127897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [HLA-DRB1 typing in Caucasians patients with neuromyelitis optica].
    Blanco Y; Ercilla-González G; Llufriu S; Casanova-Estruch B; Magraner MJ; Ramió-Torrentá L; Mendibe-Bilbao MM; Uclés-Sánchez AJ; Casado-Chocán JL; López de Munain A; Ramo-Tello C; Santos-Lasaosa S; Fernández-Bolaños Porras R; Segura-Bruna N; Sepulveda-Gázquez M; Villoslada P; Graus F; Saiz A
    Rev Neurol; 2011 Aug; 53(3):146-52. PubMed ID: 21748712
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: a high-resolution genotyping study.
    Wu JS; James I; Wei Qiu ; Castley A; Christiansen FT; Carroll WM; Mastaglia FL; Kermode AG
    Mult Scler; 2010 May; 16(5):526-32. PubMed ID: 20207784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-DRB1 and multiple sclerosis in Malta.
    Dean G; Yeo TW; Goris A; Taylor CJ; Goodman RS; Elian M; Galea-Debono A; Aquilina A; Felice A; Vella M; Sawcer S; Compston DA
    Neurology; 2008 Jan; 70(2):101-5. PubMed ID: 18057318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis.
    Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M
    Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
    Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
    Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis.
    Matsuoka T; Matsushita T; Osoegawa M; Kawano Y; Minohara M; Mihara F; Nishimura Y; Ohyagi Y; Kira J
    Mult Scler; 2008 Nov; 14(9):1181-90. PubMed ID: 18952831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The relation between the HLA-DRB1*1501 allele and the severity of multiple sclerosis in a sample of the Spanish population from the Balearic Islands: the influence exerted by sex].
    Zabay-Becerril JM; Burcet-Dardé J; Mulet-Ferrer J; Soler-Farré J; Viader-Farré C
    Rev Neurol; 2004 Jan 16-31; 38(2):118-22. PubMed ID: 14752708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A linkage study in two families with multiple sclerosis and healthy members with oligoclonal CSF immunopathy.
    Haghighi S; Andersen O; Nilsson S; Rydberg L; Wahlström J
    Mult Scler; 2006 Dec; 12(6):723-30. PubMed ID: 17262999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three allele combinations associated with multiple sclerosis.
    Favorova OO; Favorov AV; Boiko AN; Andreewski TV; Sudomoina MA; Alekseenkov AD; Kulakova OG; Gusev EI; Parmigiani G; Ochs MF
    BMC Med Genet; 2006 Jul; 7():63. PubMed ID: 16872485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of oligoclonal bands in multiple sclerosis in Japan: relevance of immunogenetic backgrounds.
    Fukazawa T; Kikuchi S; Sasaki H; Hamada K; Hamada T; Miyasaka K; Tashiro K
    J Neurol Sci; 1998 Jun; 158(2):209-14. PubMed ID: 9702693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine mapping in cerebrospinal fluid and blood in multiple sclerosis patients without oligoclonal bands.
    Vrethem M; Kvarnström M; Stenstam J; Cassel P; Gustafsson M; Landtblom AM; Ernerudh J
    Mult Scler; 2012 May; 18(5):669-73. PubMed ID: 21965416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.